CIK 0000873303 · Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 930797222
- Phone
- 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-04 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −288 | $101.34 | $29K | 13,037 |
| 2025-03-04 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −296 | $101.34 | $30K | 13,325 |
| 2025-03-04 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −281 | $101.34 | $28K | 16,515 |
| 2025-03-04 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −233 | $101.34 | $24K | 16,282 |
| 2025-03-04 | Murray Dallan Chief Customer Officer | Shares withheld for taxes | −1,685 | $101.34 | $171K | 19,821 |
| 2025-03-04 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −1,370 | $101.34 | $139K | 44,956 |
| 2025-03-04 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −1,704 | $101.34 | $173K | 65,322 |
| 2025-03-03 | Murray Dallan Chief Customer Officer | Shares withheld for taxes | −711 | $103.77 | $74K | 21,506 |
| 2025-03-03 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −719 | $103.77 | $75K | 16,796 |
| 2025-03-03 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −557 | $103.77 | $58K | 46,326 |
| 2025-03-03 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −715 | $103.77 | $74K | 67,026 |
| 2025-03-03 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −391 | $103.77 | $41K | 13,621 |
| 2025-02-11 | Estepan Ian Michael Chief Financial Officer | Grant or award · Performance Restricted Stock Units | +3,500 | 17,500 | ||
| 2025-02-11 | Rodino-Klapac Louise Head of R&D, CSO | Grant or award · Performance Restricted Stock Units | +3,500 | 17,500 | ||
| 2025-02-11 | Murray Dallan Chief Customer Officer | Grant or award · Performance Restricted Stock Units | +3,500 | 17,500 | ||
| 2025-02-11 | Arif Bilal Chief Tech Ops Officer | Grant or award · Performance Restricted Stock Units | +3,500 | 17,500 | ||
| 2025-01-29 | Estepan Ian Michael Chief Financial Officer | Option exercise | +14,267 | $12.00 | $171K | 47,963 |
| 2025-01-29 | Estepan Ian Michael Chief Financial Officer | Option exercise | +1,533 | $12.00 | $18K | 49,496 |
| 2025-01-29 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −2,613 | $117.51 | $307K | 46,883 |
| 2025-01-29 | Estepan Ian Michael Chief Financial Officer | Option exercise · Stock Option (right to buy) | −14,267 | 0 |
Page 8 of 12 · 227 trades